SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.490+1.2%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (1093)2/5/1999 9:11:00 PM
From: Anthony Wong  Read Replies (1) of 2539
 
Monsanto to Sell Biodegradable Plastic Polymers Technology

Bloomberg News
February 5, 1999, 6:53 p.m. ET

Monsanto to Sell Biodegradable Plastic Polymers Technology

St. Louis, Feb. 5 (Bloomberg) -- Monsanto Co., a leading
agricultural biotechnology company, said it will sell its
biodegradable plastics technology as part of belt-tightening
effort following the collapse last year of its planned merger
with American Home Products Corp.

Monsanto had hoped to genetically engineer canola and
mustard plants to produce biodegradable plastics. The company
made some advances, but said a commercially viable product was
five to seven years away.

The St. Louis-based company said it tried to find a partner
to help develop the business, but was unsuccessful. In December
it closed it down. Most of the 50 employees were transferred in
the preceding months. The five remaining were dismissed.

''We had hoped to use the plants as factories,'' said Diane
Herndon, a Monsanto spokeswoman, ''but the market wasn't there
for them. No one was willing to pay extra money for the
biodegradable polymer.''

Monsanto was also developing plastics using a fermentation
technology it acquired from Zeneca Plc in 1996. It charged $4.00
a pound for biodegradable polymers produced through fermentation.
Petroleum-based polymers cost 40 cents a pound. The company had
hoped to get the cost of its biotechnology-based polymers down to
60 to 80 cents.

The company will sell or license its technology in pieces or
as a package. Herndon said it is a very small business -- ''in
the millions, not hundreds of millions.''

Monsanto has successfully developed a variety of genetically
enhanced crops that resist insects and tolerate herbicides. It is
working to develop food and animal feed with improved nutritional
composition. It is stripping away all businesses that don't
relate to its main agricultural, nutrition or drug businesses.

--Toni Clarke in the Chicago newsroom (312) 692-3725 /mfr
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext